Stock Research for GRFS

Current Price


Latest Update: 2018-03-23 16:00:00

$ 20.3900
$ 20.3600
$ 20.3700

Featured Broker: TradeStation

Get the due diligence for another stock.


GRFS Stock Chart & Research Data

The GRFS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GRFS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


GRFS Due diligence Resources & Stock Charts

The GRFS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View GRFS Detailed Price Forecast - CNN Money CNN View GRFS Detailed Summary - Google Finance
Yahoo View GRFS Detailed Summary - Yahoo! Finance Zacks View GRFS Stock Research & Analysis -

Stock Analysis

TradeIdeas View GRFS Trends & Analysis - Trade-Ideas Barrons View GRFS Major Holders - Barrons
NASDAQ View GRFS Call Transcripts - NASDAQ Seeking View GRFS Breaking News & Analysis - Seeking Alpha
Spotlight View GRFS Annual Report - OTC Report View GRFS OTC Short Report -
TradeKing View GRFS Fundamentals - TradeKing Charts View GRFS SEC Filings - Bar Chart
WSJ View Historical Prices for GRFS - The WSJ Morningstar View Performance/Total Return for GRFS - Morningstar
MarketWatch View the Analyst Estimates for GRFS - MarketWatch CNBC View the Earnings History for GRFS - CNBC
StockMarketWatch View the GRFS Earnings - StockMarketWatch MacroAxis View GRFS Buy or Sell Recommendations - MacroAxis
Bullish View the GRFS Bullish Patterns - American Bulls Short Pains View GRFS Short Pain Metrics -

Social Media Mentions

StockTwits View GRFS Stock Mentions - StockTwits PennyStocks View GRFS Stock Mentions - PennyStockTweets
Twitter View GRFS Stock Mentions - Twitter Invest Hub View GRFS Investment Forum News - Investor Hub
Yahoo View GRFS Stock Mentions - Yahoo! Message Board Seeking Alpha View GRFS Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for GRFS - Insider Cow View Insider Transactions for GRFS - Insider Cow
CNBC View GRFS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for GRFS - OTC Markets
Yahoo View Insider Transactions for GRFS - Yahoo! Finance NASDAQ View Institutional Holdings for GRFS - NASDAQ

Stock Charts

FinViz View GRFS Stock Insight & Charts - StockCharts View GRFS Investment Charts -
BarChart View GRFS Stock Overview & Charts - BarChart Trading View View GRFS User Generated Charts - Trading View

Latest Financial News for GRFS

Is It Time To Buy Grifols SA. (BME:GRF) Based Off Its PE Ratio?
Posted on Thursday March 22, 2018

Grifols SA. (BME:GRF) is trading with a trailing P/E of 23.2x, which is lower than the industry average of 28.5x. While this makes GRF appear like a great stock toRead More...

Can Grifols SA. (BME:GRF) Continue To Outperform Its Industry?
Posted on Thursday March 15, 2018

Grifols SA. (BME:GRF) delivered an ROE of 18.20% over the past 12 months, which is an impressive feat relative to its industry average of 17.90% during the same period. WhileRead More...

Grifols breaks ground on $120M Clayton facility
Posted on Wednesday March 14, 2018

Barcelona, Spain-based health care product and solutions giant Grifols has broken ground on a new $120 million facility at its Johnston County site, part of a $320 million investment in Clayton by 2022. The company's latest 150,000-square-foot addition in Clayton – expected to debut in 2022 – will be a purification and filling facility, used for making hemotherapy products, according to Grifols. Juan Antonio Garcia Diaz, president of Grifols Therapeutics LLC, called the facility "crucial to Grifols’ expansion plans at the Clayton site.

Consolidated Research: 2018 Summary Expectations for B Communications, Student Transportation, Aurinia Pharmaceuticals, Grifols, S.A., NEXEO SOLUTIONS, and ASML Holding N.V. — Fundamental Analysis, Key Performance Indications
Posted on Tuesday March 13, 2018

NEW YORK, March 13, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...

Warning: DOMDocument::load(): StartTag: invalid element name in, line: 1 in /home/allsites/ on line 494

Warning: DOMDocument::load(): Extra content at the end of the document in, line: 1 in /home/allsites/ on line 494

Enter a stock symbol to view the stock details.